news – Page 3339 – pharmaceutical daily

March 14, 2019 Off

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results

FREMONT, Calif.–(BUSINESS WIRE)–Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced financial results for the
fourth quarter and year ended December 31, 2018, as well as recent
bus…

March 14, 2019 Off

Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

By BusinessWire

Lead Tri-specific T cell Activating Construct (TriTAC) candidate,
HPN424, continues to advance in a Phase 1 clinical trial for the
treatment of prostate cancer

Initial public offering, successfull…

March 14, 2019 Off

BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

By BusinessWire

Completed Acquisition of Asterias Biotherapeutics, Inc.

Completed Distribution of AgeX Therapeutics Shares to BioTime
Shareholders

Entered Into Exclusive Collaboration with Orbit Biom…

March 14, 2019 Off

Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones

By BusinessWire

Conference Call Today at 4:30 p.m. Eastern Time

WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24TTPH&src=ctag" target="_blank"gt;$TTPHlt;/agt; lt;a href="https://twitter.com/hasht…

March 14, 2019 Off

Bio-Path Holdings, Inc. Announces Closing of $18.5 Million Registered Direct Offering of Common Stock

By BusinessWire

HOUSTON–(BUSINESS WIRE)–Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology
company leveraging its proprietary DNAbilize® antisense RNAi
nanoparticle technology to develop a portfolio of targeted nucleic acid
cance…

March 14, 2019 Off

ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel

By BusinessWire

Both technologies address unmet needs for patients with celiac disease

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ImmunogenX is pleased to announce the initiation of a Phase 2 clinical
trial (named Celiac Shield™), sponsored by the Na…

March 14, 2019 Off

Biodesix VeriStrat Data Demonstrate Independent Prediction of Immunotherapy Outcomes for NSCLC Patients

By BusinessWire

New Front-Line Data Presented at Multidisciplinary Thoracic
Cancers Symposium

BOULDER, Colo. & SAN DIEGO–(BUSINESS WIRE)–Biodesix®
today presented new data demonstrating that the VeriStrat®
test is predictive of out…

March 14, 2019 Off

Global Erectile Dysfunction Drugs Market by Drug, Mode of Administration, End-user and Region (2016-2024) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Erectile
Dysfunction Drugs Market: Global Industry Analysis, Trends, Market Size,
and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report predic…

March 14, 2019 Off

Pharmacy Times Continuing Education™ to Host Special Session on Pharmacists’ Roles in the Opioid Abuse Epidemic During Directions in Pharmacy® Meetings for Spring 2019

By BusinessWire

This session will feature video segments about a family dealing with
the heartbreak of opioid addiction

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DIP2019?src=hash" target="_blank"gt…

March 14, 2019 Off

Diabetes Care Intelligence Center 2012-2023 – A 2019 Database with Forecast Coverage on Value, Volume Sales, and Price & Price Per-Capita Expenditure – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Diabetes
Care Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s
offering.

The Diabetes Care Intelligence Center (IC) is a global
intelligence database on …